pentosidine has been researched along with 4-aminophenylmercuriacetate in 1 studies
| Studies (pentosidine) | Trials (pentosidine) | Recent Studies (post-2010) (pentosidine) | Studies (4-aminophenylmercuriacetate) | Trials (4-aminophenylmercuriacetate) | Recent Studies (post-2010) (4-aminophenylmercuriacetate) |
|---|---|---|---|---|---|
| 577 | 34 | 205 | 168 | 0 | 6 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bank, RA; Bijlsma, JW; DeGroot, J; Lafeber, FP; TeKoppele, JM; Verzijl, N; Wenting-Van Wijk, MJ | 1 |
1 other study(ies) available for pentosidine and 4-aminophenylmercuriacetate
| Article | Year |
|---|---|
Age-related decrease in susceptibility of human articular cartilage to matrix metalloproteinase-mediated degradation: the role of advanced glycation end products.
Topics: Adult; Aged; Aged, 80 and over; Aging; Animals; Arginine; Arthritis, Rheumatoid; Cartilage, Articular; Cattle; Chromatography, High Pressure Liquid; Glycosaminoglycans; Humans; In Vitro Techniques; Knee Joint; Lysine; Matrix Metalloproteinases; Middle Aged; Osteoarthritis, Knee; Phenylmercuric Acetate; Ribose; Synovial Fluid | 2001 |